High Level of Fatigue in Lymphoma Patients Treated With High Dose Therapy
- 1 June 2000
- journal article
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 19 (6) , 446-456
- https://doi.org/10.1016/s0885-3924(00)00144-5
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Do patients who are treated with stem cell transplantation have a health-related quality of life comparable to the general population after 1 year?Bone Marrow Transplantation, 1999
- Quality of life following bone marrow transplantation: a comparison of patient reports with population normsBone Marrow Transplantation, 1997
- Asthenia: an important symptom in cancer patientsCancer Treatment Reviews, 1996
- Quality of life in adult cancer patients treated with bone marrow transplantation—a review of the literatureEuropean Journal Of Cancer, 1995
- Dysregulated Expression of Tumor Necrosis Factor in Chronic Fatigue Syndrome: Interrelations with Cellular Sources and Patterns of Soluble Immune Mediator ExpressionClinical Infectious Diseases, 1994
- Serum soluble tumour necrosis factor receptor 55 is increased in patients with haematological neoplasias and is associated with immune activation and weight lossEuropean Journal Of Cancer, 1993
- Treatment-related fatigue and serum interleukin-1 levels in patients during external beam irradiation for prostate cancerJournal of Pain and Symptom Management, 1993
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993
- Development of a fatigue scaleJournal of Psychosomatic Research, 1993
- Serum Levels of Lymphokines and Soluble Cellular Receptors in Primary Epstein-Barr Virus Infection and in Patients with Chronic Fatigue SyndromeThe Journal of Infectious Diseases, 1992